Skip to main content

Month: March 2022

Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in Revenue

Positioned for Accelerated Revenue Growth and to Become an SEC Reporting Company in 2022 See on website Miami, FL, March 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the year ended December 31, 2021. Key Financial Highlights for Year Ended December 31, 2021 • Revenue at $38.9 million – COVID-19 testing revenue of approximately $4.3 million – ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million • Gross margin increased to 26% in 2021, from 23% in 2020 • EBITDA increased to $167,000 in 2021 from $7,000 in 2020 • Cash balance of $1.4 million as of December 31, 2021 Business Highlights...

Continue reading

Saniona Announces Strategic Program Prioritization and Restructuring to Streamline Operational Costs

PRESS RELEASE March 29, 2022 Saniona (OMX: SANION), a clinical–stage biopharmaceutical company focused on rare diseases, today announced a strategic program reprioritization and restructuring intended to immediately and substantially reduce operating expenses and maximize the utility of current and future cash resources. The Board has resolved to implement multiple actions including a voluntary pause of the Phase 2b clinical trials of Tesomet™ for hypothalamic obesity (HO) and Prader-Willi syndrome (PWS) and a workforce reduction of approximately 30%. The decision to voluntarily pause the Phase 2b clinical trials of Tesomet is not related to the safety or efficacy of Tesomet and is entirely due to funding limitations. Comments from Rami Levin, President and CEO of Saniona:“We are extremely disappointed to have to undertake such drastic...

Continue reading

HealthEquity Named as One of The Healthiest Workplaces

Company honored with two awards for employee wellness initiatives DRAPER, Utah, March 29, 2022 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), a leading administrator of health savings accounts (HSAs) and other consumer-directed benefits, has been recognized as one of the healthiest workplaces by the Utah Worksite Wellness Council (UWWC). This includes receiving a Platinum Award, the highest ranking UWWC bestows for demonstrating an exemplary commitment to employee well-being. Additionally, HealthEquity has been recognized with an exclusive Physical Innovation Award for its Savory Living program.  “As a company that helps Americans to achieve greater health and wealth, it is imperative that we practice what we preach,” said CEO Jon Kessler. “The health and wellness of our team members is a top priority and...

Continue reading

Lowell Farms Chairman of the Board George Allen to Speak at 2022 Benzinga Cannabis Capital Conference

Cannabis executive to discuss multiple topics, including industry trends and overcoming regulatory hurdles, at North America’s leading cannabis investment conference SALINAS, Calif., March 29, 2022 (GLOBE NEWSWIRE) — George Allen, Chairman of the Board for Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), will speak at the 2022 Benzinga Cannabis Capital Conference – North America’s premier gathering of cannabis entrepreneurs and investors – during the two-day event being held April 20 and 21 at Fontainebleau Miami. Mr. Allen is scheduled to speak on the Main Stage at 10:05 a.m. EDT on Thursday, April 21. His presentation will focus on the success of Lowell Farms as one of California’s most celebrated cannabis companies, and he is also expected to discuss cannabis industry trends and overcoming regulatory hurdles while at the conference....

Continue reading

Alkame Holdings Subsidiary Earns Organic Certification for CBD Products

LAS VEGAS, March 29, 2022 (GLOBE NEWSWIRE) — Alkame Holdings, Inc. (OTC PINK: ALKM), a publicly traded diversified holding company, is pleased to announce that its wholly owned subsidiary Bell Food & Beverage Inc. has received its first USDA Organic Certification for CBD products. Alkame manufacturing subsidiaries are one of the first private label copackers to achieve this certification, accredited by Oregon Tilth. Alkame Holdings Inc.’s wholly owned subsidiary Bell Food & Beverage Inc. can now enable qualifying brands to receive USDA Organic Certification, another major milestone in capabilities for both product development and manufacturing. Alkame Holdings and its “CBD Copacker” division are committed to quality, consistency, transparency, compliance, and traceability. The company is known for its ability to manufacture...

Continue reading

Correction: Updating Webcast Link — FlexShopper, Inc. Schedules 2021 Fourth Quarter and Fiscal Year Financial Results Conference Call

Conference Call Scheduled for Thursday, March 31, 2022 at 9:00 a.m. ET BOCA RATON, Fla., March 29, 2022 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper” or the “Company”), a leading national online lease-to-own (“LTO”) retailer and LTO payment solution provider, announced today that it intends to release its financial results for its fourth quarter and year ended December 31, 2021 after the market closes on Wednesday, March 30, 2022. The Company intends to hold a conference call to discuss those results the next day, March 31 at 9:00 a.m. Eastern Time.Conference Call DetailsDate:   Thursday, March 31, 2022Time:   9:00 a.m. Eastern Time     Participant Dial-In Numbers:Domestic callers:    877-407-3944International callers:   412-902-0038Access by Webcast The call will also be simultaneously...

Continue reading

VAYK Annual Report and Update To Highlight New App and Cryptocurrency Exchange

Dallas, Texas, March 29, 2022 (GLOBE NEWSWIRE) — Vaycaychella, Inc. (OTC Pink: VAYK) today confirmed the company plans to soon publish its 2021 annual report.  In conjunction with the upcoming annual report, VAYK today announced the company plans to publish a detailed management update on the company’s latest progress and plans.  VAYK is an early-stage business building a portfolio of technology solutions to further democratize participation in the tourism market, extending more opportunity to individuals and small and medium (SMB) business operators. VAYK supports individuals and SMBs in getting into the Airbnb business.  The upcoming update will include the latest on the company’s coming new app anticipated soon updating its current award winning Peer-To-Peer (P2P) Alternative Finance Application.  The new app is designed to...

Continue reading

BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services

The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced a new partnership agreement with Summit Blue Capital for implementing a leasing and finance program for the Company’s PURE EP™ System. The Minneapolis-based Summit Blue Capital is a leader in equipment finance and leasing. It offers tailored leasing and financing solutions for its partners and clients in industries such as healthcare, manufacturing, hospitality,...

Continue reading

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2021 has been published

Company release 29th March 2022, 4:30 PM   BBS Oyj’s Annual Report for 2021 has been published 29.3.2022. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/  The Publication includes the English translation of the Annual Report and the Audited Financial Statements for 2021. The English translation of the Financial Statements for Financial Year 2021 is also available on company’s website at https://www.bbs-artebone.fi/investors/financial-reports/.  More information: Ilkka Kangasniemi, CEO ilkka.kangasniemi@bbs-artebone.fi+358 40 7080307  Distribution: Nasdaq Helsinki Oy Nasdaq Stockholm ABMain Media www.bbs-artebone.fi BBS – Bioactive Bone Substitutes Plc BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for...

Continue reading

Argentum 47, Inc. Executes a Legally Binding Letter of Intent to Acquire United Kingdom Based “The Data Source (UK) Limited”

London, United Kingdom, March 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Argentum 47, Inc. (www.arg47.com) (OTC: ARGQ) is extremely delighted to announce that management have fully executed a legally binding letter of intent to acquire UK based company, The Data Source (UK) Limited (“TDS”). Management has been in negotiations with several parties since late 2021 in order to bring value and a long-term future to the Company and its shareholders by way of a merger or acquisition. The basis of the proposed transaction is for Argentum 47 Inc. to acquire 100% of The Data Source (UK) Limited (https://www.thedatasource.co.uk/) by way of management relinquishing their personal right, title and interest in (i) 40,000,000 shares of Argentum’s issued and outstanding Series “B” Preferred Stock, (ii) 4,378,888 shares of Argentum’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.